An affinity/avidity model of peripheral T cell regulation

Journal of Clinical Investigation

Volumn 115, Issue 2, 2005, Pages 302-312

  Jiang, Hong ^a   Wu, Yilun ^a   Liang, Bitao ^a   Zheng, Zongyu ^a   Tang, Guomei ^a   Kanellopoulos, Jean ^b   Soloski, Mark ^c   Winchester, Robert ^a   Goldstein, Itamar ^a   Chess, Leonard ^a  

^a Columbia University ^*  (United States)

^b INSTITUT PASTEUR   (France)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN QA 1; CD4 ANTIGEN; CD8 ANTIGEN; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; AUTOANTIGEN; HLA ANTIGEN CLASS 1; Q SURFACE ANTIGENS;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL MATURATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN MOTIF; T LYMPHOCYTE; ANIMAL; AUTOIMMUNITY; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; SELF TOLERANCE;

EID: 85047691351     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI23879     Document Type: Article

References (48)

1. Kappler, J.W., Roehm, N., and Marrack, P. 1987. T cell tolerance by clonal elimination in the thymus. Cell. 49:273-280.
2. Bouneaud, C., Kourilsky, P., and Bousso, P. 2000. Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity. 13:829-840.
3. Kuchroo, V.K., et al. 2002. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20:101-123.
4. Jiang, H., et al. 2003. Regulatory CD8+ T cells fine tune the MBP-reactive T cell receptor Vb repertoire during EAE. Proc. Natl. Acad. Sci. U. S. A. 100:8378-8383.
5. Jiang, H., and Chess, L. 2000. The specific regulation of immune responses by CD8+ T cells restricted by the MHC class IB molecule, Qa-1. Annu. Rev. Immunol. 18:185-216.
6. Jiang, H., Zhang, S.I., and Pernis, B. 1992. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science. 256:1213-1215.
7. Koh, D.-R., et al. 1992. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science. 256:1210-1213.
8. Jiang, H., et al. 1995. Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule. Immunity. 2:185-194.
9. Jiang, H., et al. 1998. T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc. Natl. Acad. Sci. U. S. A. 95:4533-4537.
10. Jiang, H., Braunstein, N.S., Yu, B., Winchester, R., and Chess, L. 2001. CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice. Proc. Natl. Acad. Sci. U. S. A. 98:6301-6306.
11. Hu, D., et al. 2004. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat. Immuol. 5:516-523.
12. Cibotti, R., et al. 1992. Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. Proc. Natl. Acad. Sci. U. S. A. 89:416-420.
13. Cibotti, R., et al. 1994. Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J. Exp. Med. 180:861-872.
14. Cabaniols, J.P., Cibotti, R., Kourilsky, P., Kosmatopoulos, K., and Kanellopoulos, J.M. 1994. Dose-dependent T cell tolerance to an immunodominant self peptide. Eur. J. Immunol. 24:1743-1749.
15. Nanda, N.K., and Sercarz, E. 1996. A truncated T cell receptor repertoire reveals underlying immunogenicity of an antigenic determinant. J. Exp. Med. 184:1037-1043.
16. Gapin, L., et al. 1997. Determinant selection for T-cell tolerance in HEL-transgenic mice: dissociation between immunogenicity and tolerogenicity. Cell. Immunol. 177:77-85.
17. Maverakis, E., et al. 2000. T cell receptor complementarity determining region 3 length analysis reveals the absence of a characteristic public T cell repertoire in neonatal tolerance. The response in the "tolerant" mouse within the residual repertoire is quantitatively similar but qualitatively different. J. Exp. Med. 191:695-702.
18. Rees, W., et al. 1999. An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc. Natl. Acad. Sci. U. S. A. 96:9781-9786.
19. Fasso, M., et al. 2000. T cell receptor (TCR)-mediated repertoire selection and loss of TCR vbeta diversity during the initiation of a CD4(+) T cell response in vivo. J. Exp. Med. 192:1719-1730.
20. Targoni, O.S., and Lehmann, P.V. 1998. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187:2055-2063.
21. Jiang, H., and Chess, L. 2004. An intergrated model of immunoregulation mediated by regulatory T cell subsets. Adv. Immunol. 83:1-14.
22. Pullen, A.M., Marrack, P., and Kappler, J.W. 1988. The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature. 335:796-801.
23. Sandberg, J.K., et al. 2000. T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity. J. Immunol. 165:25-33.
24. Garcia, K.C., et al. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science. 279:1166-1172.
25. Kawai, K., and Ohashi, P.S. 1995. Immunological function of a defined T-cell population tolerized to low-affinity self antigens. Nature. 374:68-69.
26. Goldrath, A.W., and Bevan, M.J. 1999. Selecting and maintaining a diverse T-cell repertoire. Nature. 402:255-262.
27. McHeyzer-Williams, M.G., and Davis, M.M. 1995. Antigen-specific development of primary and memory T cells in vivo. Science. 268:106-111.
28. Savage, P.A., Boniface, J.J., and Davis, M.M. 1999. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity. 10:485-492.
29. Busch, D.H., and Pamer, E.G. 1999. T cell affinity maturation by selective expansion during infection. J. Exp. Med. 189:701-710.
30. Busch, D.H., Pilip, I., and Pamer, E.G. 1998. Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection. J. Exp. Med. 188:61-70.
31. McHeyzer-Williams, L.J., Panus, J.F., Mikszta, J.A., and McHeyzer-Williams, M.G. 1999. Evolution of antigen-specific T cell receptors in vivo: preimmune and antigen-driven selection of preferred complementarity- determining region 3 (CDR3) motifs. J. Exp. Med. 189:1823-1838.
32. Kim, D.T., Rothbard, J.B., Bloom, D.D., and Pathman, C.G. 1996. Quantitative analysis of T cell activation: role of TCR/ligand density and TCR affinity. J. Immunol. 156:2737-2742.
33. Landolfi, N.F., Rich, R.R., and Cook, R.G. 1985. The Qa-1 alloantigens. III. Biochemical analysis of the structure and extent of polymorphism of the Qa-1 allelic products. J. Immunol. 135:1264-1270.
34. Connolly, D.J., et al. 1993. A cDNA clone encoding the mouse Qa-1a histocompatibility antigen and proposed structure of the putative peptide binding site. J. Immunol. 151:6089-6098.
35. Shawar, S.M., Vyas, J.M., Rodgers, J.R., and Rich, R.R. 1994. Antigen presentation by major histocompatibility complex class I-B molecules. Annu. Rev. Immunol. 12:839-880.
36. Aldrich, C.J., Rodgers, J.R., and Rich, R.R. 1988. Regulation of Qa-1 expression and determinant modification by an H-2D-linked gene, Qdm. Immunogenetics. 28:334-344.
37. Aldrich, C.J., et al. 1992. T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter. J. Immunol. 149:3773-3777.
38. Lowen, L.C., Aldrich, C.J., and Forman, J. 1993. Analysis of T cell receptors specific for recognition of class IB antigens. J. Immunol. 151:6155-6165.
39. Kurepa, Z., Hasemann, C.A., and Forman, J. 1998. Qa-1b binds conserved class I leader peptides derived from several mammalian species. J. Exp. Med. 188:973-978.
40. Cotterill, L.A., et al. 1997. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide. Eur. J. Immunol. 27:2123-2132.
41. Imani, F., and Soloski, M.J. 1991. Heat shock proteins can regulate expression of the Tla region-encoded class Ib molecule Qa-1. Proc. Natl. Acad. Sci. U. S. A. 88:10475-10479.
42. Chun, T., et al. 1998. Constitutive and regulated expression of the class IB molecule Qa-1 in pancreatic beta cells. Immunology. 94:64-71.
43. Vance, R.E., Kraft, J.R., Altman, J.D., Jensen, P.E., and Raulet, D.H. 1998. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188:1841-1848.
44. Salcedo, M., Bousso, P., Ljunggren, H.G., Kourilsky, P., and Abastado, J.P. 1998. The Qa-1b molecule binds to a large subpopulation of murine NK cells. Eur. J. Immunol. 28:4356-4361.
45. Lo, W.F., Ong, H., Metcalf, E.S., and Soloski, M.J. 1999. T cell responses to Gram-negative intracellular bacterial pathogens: a role for CD8+ T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J. Immunol. 162:5398-5406.
46. Wells, A.D., Gudmundsdottir, H., and Turka, L.A. 1997. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100:3173-3183.
47. Suchin, E.J., et al. 2001. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol 166:973-981.
48. Jabri, B., et al. 2002. TCR specificity dictates CD94/ NKG2A expression by human CTL. Immunity. 17:487-499.